GP
ELV icon

GLG Partners’s Elevance Health ELV Stock Holding History

GLG Partners’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-165,557
Closed -$23.1M – 436
2015
Q4 		$23.1M Buy
165,557
+38,544
+30% +$5.31M 0.73% 34
2015
Q3 		$17.8M Buy
+127,013
New +$19.1M 0.47% 61
2013
Q3 		– Sell
-3,588
Closed -$294K – 193
2013
Q2 		$294K Buy
+3,588
New +$269K 0.01% 261

Other funds holding ELV

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

GLG Partners's ELV Position: Q1 2016 in Review

GLG Partners sold out of Elevance Health (ELV) in Q1 2016, closing a stake of 165,557 shares — an estimated $23.1M sold.

GLG Partners first reported a position in ELV in Q2 2013 and held it in 3 quarters. The position peaked at $23.1M in Q4 2015. 772 funds tracked by Wall St. Rank hold ELV as of Q1 2016.

  • GLG Partners reported no remaining Elevance Health position as of Q1 2016 after selling out during the quarter.
  • GLG Partners sold 165,557 Elevance Health shares in Q1 2016, an estimated $23.1M.
  • GLG Partners first reported a position in Elevance Health in Q2 2013 and held it in 3 quarters.
  • GLG Partners's Elevance Health position peaked at $23.1M in Q4 2015.
  • 772 funds tracked by Wall St. Rank held Elevance Health as of Q1 2016.

Based on GLG Partners's 13F filing for Q1 2016, filed 16 May 2016.